Methyl 2-fluoro-6-iodobenzoate, 97%, 5g

2-Bromo-3-fluorophenol, 98.0%, 5g

Butyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate, 95.0%, 5g

1-(4-Fluoro-benzyl)-3-nitro-1H-pyrazole, 5g

3-Benzamido-N-(2-chlorobenzyl)benzamide, 98%, 2.5g

6-Methoxy-2-methylpyrimidin-4-amine, 95.0%, 250mg

HPLC column NUCLEODUR® 100-5 C18 ec 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

2-(2-Thienylidene)-3,4-dimethoxyacetophenone, 98.0%, 1g

Methyl 6-cyano-1H-indole-3-carboxylate, 97%, 1g

3-Nitrophenol>98.0%(GC)(T)25g

3-Amino-4-methylbenzyl alcohol, 95.0%, 250mg

Dialysis membrane Spectra/Por® Biotech CE MWCO 50,000, 10 mm, 1 Piece(s)

CDTA, min. 99%, for synthesis, 1 kg, plastic packaging.